COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...

Updated COVID vaccines are necessary, just as flu vaccines are updated because immunity wanes with time, even among those ...

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

BioNTech's colorectal cancer vaccine just collapsed in a Phase 2 trial, dragging Moderna down with it despite last week's ...

The company is coming back into the spotlight thanks to recent developments.

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...

The Food and Drug Administration approved new seasonal Covid-19 vaccine formulas made by Moderna, Pfizer and BioNTech.

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. Pfizer Inc. signage is seen on July 22, 2020 in New York City. Pfizer and partner BioNTech said they will halt a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...